Vulvar Cancer

Vulvar Cancer


Charles H. Matthews and Daniel G. Petereit



image Background



Approximately how many pts are affected by vulvar cancer per yr in the U.S.? What is the incidence of vulvar cancer in the U.S.?


~3,500 pts are affected by vulvar cancer per yr in the U.S. The incidence is 1/100,000 people.


Vulvar cancer accounts for what % of gyn malignancies? What % of all malignancies in women are vulvar malignancies?


Vulvar cancer represents 3%–5% of all gyn malignancies. This comprises 1%–2% of all cancers in women.


What are the risk factors for vulvar cancer?


Risk factors for vulvar cancer:




  1. Increasing age



  2. HPV



  3. Vulvar intraepithelial neoplasia (VIN)



  4. Bowen Dz (squamous cell CIS)



  5. Paget Dz (lesions arising from Bartholin, urethra, or rectum)



  6. Erythroplasia



  7. Chronic vaginitis



  8. Leukoplakia



  9. Smoking



  10. Employment in laundry facilities



  11. Immune deficiency


What HPV subtypes are associated with vulvar cancer?


HPV subtypes associated with vulvar cancer include 6, 16, 18, and 33.


What is the function of HPV-associated oncoproteins?


It is thought that HPV-associated oncoproteins bind and inactivate tumor suppressor proteins such as Rb, p53, and p21.


What are the 7 subsites of the vulva?


Subsites of the vulva:




  1. Labia majora



  2. Labia minora



  3. Mons pubis



  4. Clitoris



  5. Vaginal vestibule



  6. Perineal body



  7. Posterior forchette


What are the most common presenting Sx of pts with vulvar cancer?


Common presenting Sx of vulvar cancer: pruritis, vulvar discomfort or pain, dysuria, oozing or bleeding, and difficulty with defecation


In which subsites does vulvar cancer most commonly arise?


70% of vulvar cancers arise from the labia majora/minora.


How is “locally advanced” vulvar cancer defined?


Locally advanced vulvar cancer is defined as a vulvar tumor burden that cannot be resected without exenterative surgery.


What % of vulvar cancers are locally advanced at Dx?


30% of vulvar cancers are locally advanced at Dx.


What are the 1st-, 2nd-, and 3rd-echelon LN regions in vulvar cancer, and which subsite is associated with skip nodal mets?


LN regions in vulvar cancer:




  1. 1st echelon: superficial inguinofemoral



  2. 2nd echelon: deep inguinofemoral and femoral



  3. 3rd echelon: external iliac nodes


The clitoris can drain directly to the deep inguinofemoral or pelvic nodes.


What are the 2 strongest predictors of LN involvement in vulvar cancer?


The 2 strongest predictors of LN involvement in vulvar cancer are tumor grade and DOI.


Estimate the risk of inguinal LN involvement based on the DOI of a cervical tumor: <1 mm, 1–3 mm, 3–5 mm, and >5 mm.


LN involvement by cervical tumor DOI:




  1. <1 mm: <5%



  2. 1–3 mm: 8%



  3. 3–5 mm: 27%



  4. >5 mm: 34%


(Hacker NF et al., Cancer 1993)


Estimate the risk of inguinal LN involvement based on the vulvar cancer FIGO stage.


LN involvement by the vulvar cancer FIGO stage:




  1. Stage I: 17%



  2. Stage II: 40%



  3. Stage III: 30%–80%



  4. Stage IV: 80%–100%


What histology constitutes the vast majority of vulvar cancers? Name 3 other histologies of tumors found on the vulva.


The most common vulvar histology is squamous cell carcinoma (80%–90%). Other histologies include melanoma, basal cell, Merkel cell, sarcoma, and adenocarcinomas of the Bartholin glands.


What % of vulvar cancers are multifocal?


~5% of vulvar cancers are multifocal.


image Workup/Staging



What is the Bx approach for small (<1 cm) vulvar lesions?

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Feb 12, 2017 | Posted by in ONCOLOGY | Comments Off on Vulvar Cancer

Full access? Get Clinical Tree

Get Clinical Tree app for offline access